ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1680891
This article is part of the Research TopicDietary Prevention and Management of Type-2 DiabetesView all 4 articles
The Impact of Glycated Hemoglobin Trajectories on Hypertension Risk: A Retrospective Cohort Study
Provisionally accepted- 1Department of Radiology, Henan Provincial People's Hospital, Zhengzhou, China
- 2The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- 3Department of Medical Imaging, Henan University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China
- 4Department of Nuclear Medicine, Henan Provincial People's Hospital, Zhengzhou, China
- 5Henan Provincial People's Hospital, Zhengzhou, China
- 6Henan Provincial People's Hospital Department of Hypertension, Zhengzhou, China
- 7Department of Health Management, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Chronic Health Management Laboratory, Zhengzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Glycated hemoglobin (HbA1c) reliably reflects long-term glucose control and has been linked to hypertension development. This study investigates the relationship between baseline HbA1c levels, HbA1c trajectories, and hypertension risk. Methods: This retrospective cohort study included 10,138 adults from health screenings at Henan Provincial People's Hospital (January 2018-January 2025). Mean age was 54.03±12.97 years, with 31.44% women and mean follow-up of 43.92 months. We analyzed hypertension incidence across HbA1c groups using Kaplan-Meier curves and identified HbA1c trajectory patterns using latent class trajectory modeling (LCTM). Cox proportional hazards models evaluated associations between baseline HbA1c tertiles, HbA1c trajectories, and hypertension risk. Restricted cubic splines explored dose-response relationships. Results: During follow-up, 3,452 participants (34.05%) developed hypertension. After adjustment, participants in the highest baseline HbA1c tertile had significantly increased hypertension risk versus the lowest tertile (HR=1.49, 95%CI: 1.31-1.70). LCTM identified three distinct trajectories: low-stable (5.57±0.36%), medium-stable (6.45±0.59%), and high-stable (8.42±1.39%). Compared to low-stable trajectory, medium-stable and high-stable groups showed significantly increased risks (HR=1.38, 95%CI: 1.24-1.53; HR=2.71, 95%CI: 2.21-3.32, respectively). Restricted cubic spline analysis revealed a J-shaped relationship with an inflection point at HbA1c=5.70% (P for nonlinearity<0.001). Conclusion: Elevated baseline HbA1c levels, particularly above 5.70%, and medium-to-high stable HbA1c trajectories significantly increase hypertension risk among adults undergoing health screening. HbA1c could serve as a valuable biomarker for hypertension risk assessment.
Keywords: Glycated hemoglobin, Hypertension, trajectory analysis, Prospective longitudinal study, health screening
Received: 06 Aug 2025; Accepted: 23 Oct 2025.
Copyright: © 2025 Sun, Shen, Liu, Zhao, Ji, Li, Zhi, Li, Wu, Wang, Liu, Li and Hao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yongli Li, shyliyongli@126.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.